{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:58:29Z","timestamp":1792627109713,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":113,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811057649","type":"print"},{"value":"9789811057656","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-5765-6_8","type":"book-chapter","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T09:09:35Z","timestamp":1508404175000},"page":"129-146","source":"Crossref","is-referenced-by-count":17,"title":["Hepatitis C Virus-Associated Cancers"],"prefix":"10.1007","author":[{"given":"Zhigang","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"issue":"Suppl 1","key":"8_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74\u201381","journal-title":"Liver Int"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245\u20131255","journal-title":"Lancet"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359\u2013362","journal-title":"Science"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","volume":"244","author":"G Kuo","year":"1989","unstructured":"Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B-hepatitis. Science 244:362\u2013364","journal-title":"Science"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","volume":"39","author":"DB Strader","year":"2004","unstructured":"Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver D (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147\u20131171","journal-title":"Hepatology"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C Martel de","year":"2015","unstructured":"de Martel C, Maucort-Boulch D, Plummer M, Franceschi S (2015) World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62:1190\u20131200","journal-title":"Hepatology"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","volume":"20","author":"A Wasley","year":"2000","unstructured":"Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20:1\u201316","journal-title":"Semin Liver Dis"},{"key":"8_CR8","first-page":"1","volume":"369","author":"P Simmonds","year":"2013","unstructured":"Simmonds P (2013) The origin of hepatitis C virus. Curr Top Microbiol Immunol 369:1\u201315","journal-title":"Curr Top Microbiol Immunol"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","volume":"151","author":"BJ McMahon","year":"1985","unstructured":"McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE (1985) Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151:599\u2013603","journal-title":"J Infect Dis"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","volume":"5","author":"D Moradpour","year":"2007","unstructured":"Moradpour D, Penin F, Rice CM (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5:453\u2013463","journal-title":"Nat Rev Microbiol"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"e1003056","DOI":"10.1371\/journal.ppat.1003056","volume":"8","author":"I Romero-Brey","year":"2012","unstructured":"Romero-Brey I, Merz A, Chiramel A, Lee JY, Chlanda P, Haselman U, Santarella-Mellwig R, Habermann A, Hoppe S, Kallis S, Walther P, Antony C, Krijnse-Locker J, Bartenschlager R (2012) Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog 8:e1003056","journal-title":"PLoS Pathog"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","volume":"10","author":"K Gill","year":"2016","unstructured":"Gill K, Ghazinian H, Manch R, Gish R (2016) Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int 10:415\u2013423","journal-title":"Hepatol Int"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","volume":"312","author":"A Kohli","year":"2014","unstructured":"Kohli A, Shaffer A, Sherman A, Kottilil S (2014) Treatment of hepatitis C: a systematic review. JAMA 312:631\u2013640","journal-title":"JAMA"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","volume":"64","author":"GR Foster","year":"2016","unstructured":"Foster GR, Irving WL, Cheung MC, Walker AJ, Hudson BE, Verma S, McLauchlan J, Mutimer DJ, Brown A, Gelson WT, MacDonald DC, Agarwal K, Hcv Research UK (2016) Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol 64:1224\u20131231","journal-title":"J Hepatol"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.gastro.2015.10.013","volume":"150","author":"MS Sulkowski","year":"2016","unstructured":"Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, Morelli G, Darling JM, Feld JJ, Brown RS, Frazier LM, Stewart TG, Fried MW, Nelson DR, Jacobson IM, Group H-TS (2016) Effectiveness of Simeprevir Plus Sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection. Gastroenterology 150:419\u2013429","journal-title":"Gastroenterology"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2015.07.001","volume":"149","author":"E Lawitz","year":"2015","unstructured":"Lawitz E, Makara M, Akarca US, Thuluvath PJ, Preotescu LL, Varunok P, Morillas RM, Hall C, Mobashery N, Redman R, Pilot-Matias T, Vilchez RA, Hezode C (2015) Efficacy and safety of ombitasvir, paritaprevir, and ritonavir in an open-label study of patients with genotype 1b chronic hepatitis C virus infection with and without cirrhosis. Gastroenterology 149:971\u2013980. e971","journal-title":"Gastroenterology"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","volume":"370","author":"F Poordad","year":"2014","unstructured":"Poordad F, Hezode C, Trinh R, Kowdley KV, Zeuzem S, Agarwal K, Shiffman ML, Wedemeyer H, Berg T, Yoshida EM, Forns X, Lovell SS, Da Silva-Tillmann B, Collins CA, Campbell AL, Podsadecki T, Bernstein B (2014) ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. N Engl J Med 370:1973\u20131982","journal-title":"N Engl J Med"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.27826","volume":"62","author":"KR Reddy","year":"2015","unstructured":"Reddy KR, Bourliere M, Sulkowski M, Omata M, Zeuzem S, Feld JJ, Lawitz E, Marcellin P, Welzel TM, Hyland R, Ding X, Yang J, Knox S, Pang P, Dvory-Sobol H, Subramanian GM, Symonds W, McHutchison JG, Mangia A, Gane E, Mizokami M, Pol S, Afdhal N (2015) Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: an integrated safety and efficacy analysis. Hepatology 62:79\u201386","journal-title":"Hepatology"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","volume":"149","author":"M Charlton","year":"2015","unstructured":"Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS Jr, Fried MW, Terrault NA, O\u2019Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N, Investigators S (2015) Ledipasvir and Sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease. Gastroenterology 149:649\u2013659","journal-title":"Gastroenterology"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","volume":"63","author":"F Poordad","year":"2016","unstructured":"Poordad F, Schiff ER, Vierling JM, Landis C, Fontana RJ, Yang R, McPhee F, Hughes EA, Noviello S, Swenson ES (2016) Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence. Hepatology 63:1493\u20131505","journal-title":"Hepatology"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1038\/srep09954","volume":"5","author":"CS Hsu","year":"2015","unstructured":"Hsu CS, Chao YC, Lin HH, Chen DS, Kao JH (2015) Systematic review: impact of interferon-based therapy on HCV-related hepatocellular carcinoma. Sci Rep 5:9954","journal-title":"Sci Rep"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","volume":"15","author":"EA Mesri","year":"2014","unstructured":"Mesri EA, Feitelson MA, Munger K (2014) Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe 15:266\u2013282","journal-title":"Cell Host Microbe"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","volume":"13","author":"A Arzumanyan","year":"2013","unstructured":"Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13:123\u2013135","journal-title":"Nat Rev Cancer"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coviro.2015.09.003","volume":"14","author":"JK Mitchell","year":"2015","unstructured":"Mitchell JK, Lemon SM, McGivern DR (2015) How do persistent infections with hepatitis C virus cause liver cancer? Curr Opin Virol 14:101\u2013108","journal-title":"Curr Opin Virol"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","volume":"65","author":"G Giannelli","year":"2016","unstructured":"Giannelli G, Koudelkova P, Dituri F, Mikulits W (2016) Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J hepatol 65:798","journal-title":"J hepatol"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890","journal-title":"Cell"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655\u20131669","journal-title":"Gastroenterology"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"e27496","DOI":"10.1371\/journal.pone.0027496","volume":"6","author":"J Liu","year":"2011","unstructured":"Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou F, Shan X, Cai X, Chen Q, Ling N, Zhang B, Bi Y, Chen K, Ren H, Huang A, He TC, Tang N (2011) Enhancement of canonical Wnt\/beta-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. PLoS One 6:e27496","journal-title":"PLoS One"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2009.06.026","volume":"51","author":"CY Park","year":"2009","unstructured":"Park CY, Choi SH, Kang SM, Kang JI, Ahn BY, Kim H, Jung G, Choi KY, Hwang SB (2009) Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 51:853\u2013864","journal-title":"J Hepatol"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1074\/jbc.M312245200","volume":"279","author":"A Street","year":"2004","unstructured":"Street A, Macdonald A, Crowder K, Harris M (2004) The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 279:12232\u201312241","journal-title":"J Biol Chem"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1128\/JVI.79.8.5006-5016.2005","volume":"79","author":"A Street","year":"2005","unstructured":"Street A, Macdonald A, McCormick C, Harris M (2005) Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol 79:5006\u20135016","journal-title":"J Virol"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1371\/journal.ppat.0030139","volume":"3","author":"T Munakata","year":"2007","unstructured":"Munakata T, Liang Y, Kim S, McGivern DR, Huibregtse J, Nomoto A, Lemon SM (2007) Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog 3:1335\u20131347","journal-title":"PLoS Pathog"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"18159","DOI":"10.1073\/pnas.0505605102","volume":"102","author":"T Munakata","year":"2005","unstructured":"Munakata T, Nakamura M, Liang Y, Li K, Lemon SM (2005) Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 102:18159\u201318164","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/onc.2012.484","volume":"32","author":"MR Higgs","year":"2013","unstructured":"Higgs MR, Lerat H, Pawlotsky JM (2013) Hepatitis C virus-induced activation of beta-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events. Oncogene 32:4683\u20134693","journal-title":"Oncogene"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jhep.2013.07.036","volume":"59","author":"N Benzoubir","year":"2013","unstructured":"Benzoubir N, Lejamtel C, Battaglia S, Testoni B, Benassi B, Gondeau C, Perrin-Cocon L, Desterke C, Thiers V, Samuel D, Levrero M, Brechot C, Bourgeade MF (2013) HCV core-mediated activation of latent TGF-beta via thrombospondin drives the crosstalk between hepatocytes and stromal environment. J Hepatol 59:1160\u20131168","journal-title":"J Hepatol"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"e1000269","DOI":"10.1371\/journal.ppat.1000269","volume":"5","author":"KA Walters","year":"2009","unstructured":"Walters KA, Syder AJ, Lederer SL, Diamond DL, Paeper B, Rice CM, Katze MG (2009) Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 5:e1000269","journal-title":"PLoS Pathog"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1128\/JVI.00280-11","volume":"85","author":"RP Kannan","year":"2011","unstructured":"Kannan RP, Hensley LL, Evers LE, Lemon SM, McGivern DR (2011) Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J Virol 85:7989\u20138001","journal-title":"J Virol"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"26603","DOI":"10.1074\/jbc.M111.225672","volume":"286","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wang Y, Xu Y, Tong W, Pan T, Li J, Sun S, Shao J, Ding H, Toyoda T, Yuan Z (2011) Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP). J Biol Chem 286:26603\u201326615","journal-title":"J Biol Chem"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.3748\/wjg.v13.i36.4865","volume":"13","author":"R Fischer","year":"2007","unstructured":"Fischer R, Baumert T, Blum HE (2007) Hepatitis C virus infection and apoptosis. World J Gastroenterol 13:4865\u20134872","journal-title":"World J Gastroenterol"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/onc.2010.594","volume":"30","author":"DR McGivern","year":"2011","unstructured":"McGivern DR, Lemon SM (2011) Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30:1969\u20131983","journal-title":"Oncogene"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/he.2000.7123","volume":"31","author":"F Calabrese","year":"2000","unstructured":"Calabrese F, Pontisso P, Pettenazzo E, Benvegnu L, Vario A, Chemello L, Alberti A, Valente M (2000) Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 31:1153\u20131159","journal-title":"Hepatology"},{"key":"8_CR42","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/jhep.2001.28229","volume":"34","author":"H Bantel","year":"2001","unstructured":"Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K (2001) Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34:758\u2013767","journal-title":"Hepatology"},{"key":"8_CR43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339\u2013346","journal-title":"Nat Genet"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","volume":"101","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM, Lai MY, Lai MM (2004) Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101:4262\u20134267","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.4049\/jimmunol.1000618","volume":"185","author":"K Machida","year":"2010","unstructured":"Machida K, McNamara G, Cheng KT, Huang J, Wang CH, Comai L, Ou JH, Lai MM (2010) Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1\/Mre11\/Rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol 185:6985\u20136998","journal-title":"J Immunol"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1128\/JVI.78.16.8835-8843.2004","volume":"78","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KT, Sung VM, Lee KJ, Levine AM, Lai MM (2004) Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78:8835\u20138843","journal-title":"J Virol"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1128\/JVI.00321-06","volume":"80","author":"K Machida","year":"2006","unstructured":"Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM (2006) Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 80:7199\u20137207","journal-title":"J Virol"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.virol.2007.08.037","volume":"370","author":"CK Lai","year":"2008","unstructured":"Lai CK, Jeng KS, Machida K, Cheng YS, Lai MM (2008) Hepatitis C virus NS3\/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology 370:295\u2013309","journal-title":"Virology"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/cmi.12489","volume":"17","author":"Z Yi","year":"2015","unstructured":"Yi Z, Chen J, Kozlowski M, Yuan Z (2015) Innate detection of hepatitis B and C virus and viral inhibition of the response. Cell Microbiol 17:1295\u20131303","journal-title":"Cell Microbiol"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","volume":"54","author":"S Marukian","year":"2011","unstructured":"Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, Rice CM, Dustin LB (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54:1913\u20131923","journal-title":"Hepatology"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"e1003330","DOI":"10.1371\/journal.ppat.1003330","volume":"9","author":"AA Negash","year":"2013","unstructured":"Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, Gale M Jr (2013) IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 9:e1003330","journal-title":"PLoS Pathog"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1128\/JVI.00974-13","volume":"87","author":"H Nishitsuji","year":"2013","unstructured":"Nishitsuji H, Funami K, Shimizu Y, Ujino S, Sugiyama K, Seya T, Takaku H, Shimotohno K (2013) Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells. J Virol 87:8169\u20138178","journal-title":"J Virol"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1053\/j.gastro.2010.03.008","volume":"138","author":"W Lin","year":"2010","unstructured":"Lin W, Tsai WL, Shao RX, Wu G, Peng LF, Barlow LL, Chung WJ, Zhang L, Zhao H, Jang JY, Chung RT (2010) Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138:2509\u20132518. 2518 e2501","journal-title":"Gastroenterology"},{"key":"8_CR54","doi-asserted-by":"crossref","first-page":"22487","DOI":"10.1038\/srep22487","volume":"6","author":"P Chusri","year":"2016","unstructured":"Chusri P, Kumthip K, Hong J, Zhu C, Duan X, Jilg N, Fusco DN, Brisac C, Schaefer EA, Cai D, Peng LF, Maneekarn N, Lin W, Chung RT (2016) HCV induces transforming growth factor beta1 through activation of endoplasmic reticulum stress and the unfolded protein response. Sci Rep 6:22487","journal-title":"Sci Rep"},{"key":"8_CR55","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/JVI.02976-15","volume":"90","author":"MH Jee","year":"2016","unstructured":"Jee MH, Hong KY, Park JH, Lee JS, Kim HS, Lee SH, Jang SK (2016) New mechanism of hepatic fibrogenesis: hepatitis C virus infection induces transforming growth factor beta1 production through glucose-regulated protein 94. J Virol 90:3044\u20133055","journal-title":"J Virol"},{"key":"8_CR56","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1074\/jbc.M512438200","volume":"281","author":"SH Choi","year":"2006","unstructured":"Choi SH, Hwang SB (2006) Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein. J Biol Chem 281:7468\u20137478","journal-title":"J Biol Chem"},{"key":"8_CR57","doi-asserted-by":"crossref","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri E, Santoro MM (2016) ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis 7:e2253","journal-title":"Cell Death Dis"},{"key":"8_CR58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20110367","volume":"208","author":"E Naik","year":"2011","unstructured":"Naik E, Dixit VM (2011) Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 208:417\u2013420","journal-title":"J Exp Med"},{"key":"8_CR59","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931\u2013947","journal-title":"Nat Rev Drug Discov"},{"key":"8_CR60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jcp.50.5.401","volume":"50","author":"V Paradis","year":"1997","unstructured":"Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, Opolon P, Holstege A, Poynard T, Bedossa P (1997) In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 50:401\u2013406","journal-title":"J Clin Pathol"},{"key":"8_CR61","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0168-8278(99)80128-7","volume":"30","author":"G Barbaro","year":"1999","unstructured":"Barbaro G, Di Lorenzo G, Ribersani M, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Barbarini G (1999) Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 30:774\u2013782","journal-title":"J Hepatol"},{"key":"8_CR62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.freeradbiomed.2006.11.001","volume":"42","author":"N Fujita","year":"2007","unstructured":"Fujita N, Horiike S, Sugimoto R, Tanaka H, Iwasa M, Kobayashi Y, Hasegawa K, Ma N, Kawanishi S, Adachi Y, Kaito M (2007) Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic Biol Med 42:353\u2013362","journal-title":"Free Radic Biol Med"},{"key":"8_CR63","first-page":"263","volume":"369","author":"D Yamane","year":"2013","unstructured":"Yamane D, McGivern DR, Masaki T, Lemon SM (2013) Liver injury and disease pathogenesis in chronic hepatitis C. Curr Top Microbiol Immunol 369:263\u2013288","journal-title":"Curr Top Microbiol Immunol"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","volume":"4","author":"K Moriya","year":"1998","unstructured":"Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065\u20131067","journal-title":"Nat Med"},{"key":"8_CR65","first-page":"4365","volume":"61","author":"K Moriya","year":"2001","unstructured":"Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61:4365\u20134370","journal-title":"Cancer Res"},{"key":"8_CR66","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1172\/JCI118304","volume":"96","author":"KS Lee","year":"1995","unstructured":"Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461\u20132468","journal-title":"J Clin Invest"},{"key":"8_CR67","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1016\/S0021-9258(19)84800-7","volume":"264","author":"M Chojkier","year":"1989","unstructured":"Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA (1989) Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. a role for lipid peroxidation? J Biol Chem 264:16957\u201316962","journal-title":"J Biol Chem"},{"key":"8_CR68","first-page":"210","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nature reviews. Immunology 10:210\u2013215","journal-title":"Immunology"},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3727\/105221614X13919976902057","volume":"16","author":"MC Wallace","year":"2014","unstructured":"Wallace MC, Friedman SL (2014) Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development. Gene Expr 16:77\u201384","journal-title":"Gene Expr"},{"key":"8_CR70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332\u2013337","journal-title":"Nature"},{"key":"8_CR71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12876-015-0291-5","volume":"15","author":"AI Thompson","year":"2015","unstructured":"Thompson AI, Conroy KP, Henderson NC (2015) Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC Gastroenterol 15:63","journal-title":"BMC Gastroenterol"},{"key":"8_CR72","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gutjnl-2013-305634","volume":"64","author":"A Florimond","year":"2015","unstructured":"Florimond A, Chouteau P, Bruscella P, Le Seyec J, Merour E, Ahnou N, Mallat A, Lotersztajn S, Pawlotsky JM (2015) Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication. Gut 64:957\u2013965","journal-title":"Gut"},{"key":"8_CR73","doi-asserted-by":"crossref","unstructured":"Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M, Zampino R (2016) NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations. Int J Mol Sci 17","DOI":"10.3390\/ijms17060803"},{"key":"8_CR74","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","volume":"99","author":"AI Su","year":"2002","unstructured":"Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG, Chisari FV (2002) Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 99:15669\u201315674","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1099\/vir.0.19724-0","volume":"85","author":"T Alonzi","year":"2004","unstructured":"Alonzi T, Agrati C, Costabile B, Cicchini C, Amicone L, Cavallari C, Rocca CD, Folgori A, Fipaldini C, Poccia F, Monica NL, Tripodi M (2004) Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol 85:1509\u20131520","journal-title":"J Gen Virol"},{"key":"8_CR76","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2002.31001","volume":"122","author":"H Lerat","year":"2002","unstructured":"Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122:352\u2013365","journal-title":"Gastroenterology"},{"key":"8_CR77","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","volume":"94","author":"G Barba","year":"1997","unstructured":"Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Brechot C (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94:1200\u20131205","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","volume":"16","author":"G Perlemuter","year":"2002","unstructured":"Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y, Koike K, Pessayre D, Chapman J, Barba G, Brechot C (2002) Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J: Off Publ Fed Am Soc Exp Biol 16:185\u2013194","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"8_CR79","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0168-8278(00)00036-2","volume":"34","author":"L Serfaty","year":"2001","unstructured":"Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R (2001) Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34:428\u2013434","journal-title":"J Hepatol"},{"key":"8_CR80","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","volume":"126","author":"A Lonardo","year":"2004","unstructured":"Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP (2004) Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 126:586\u2013597","journal-title":"Gastroenterology"},{"key":"8_CR81","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/gast.1997.v113.pm9322499","volume":"113","author":"K Houglum","year":"1997","unstructured":"Houglum K, Venkataramani A, Lyche K, Chojkier M (1997) A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 113:1069\u20131073","journal-title":"Gastroenterology"},{"key":"8_CR82","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep.26770","volume":"59","author":"S Wieland","year":"2014","unstructured":"Wieland S, Makowska Z, Campana B, Calabrese D, Dill MT, Chung J, Chisari FV, Heim MH (2014) Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology 59:2121\u20132130","journal-title":"Hepatology"},{"key":"8_CR83","first-page":"1271","volume":"141","author":"MA Gerber","year":"1992","unstructured":"Gerber MA, Shieh YS, Shim KS, Thung SN, Demetris AJ, Schwartz M, Akyol G, Dash S (1992) Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol 141:1271\u20131277","journal-title":"Am J Pathol"},{"key":"8_CR84","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/1097-0142(19940501)73:9<2253::AID-CNCR2820730904>3.0.CO;2-9","volume":"73","author":"Y Haruna","year":"1994","unstructured":"Haruna Y, Hayashi N, Kamada T, Hytiroglou P, Thung SN, Gerber MA (1994) Expression of hepatitis C virus in hepatocellular carcinoma. Cancer 73:2253\u20132258","journal-title":"Cancer"},{"key":"8_CR85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-0934(00)00199-3","volume":"90","author":"S Dash","year":"2000","unstructured":"Dash S, Saxena R, Myung J, Rege T, Tsuji H, Gaglio P, Garry RF, Thung SN, Gerber MA (2000) HCV RNA levels in hepatocellular carcinomas and adjacent non-tumorous livers. J Virol Methods 90:15\u201323","journal-title":"J Virol Methods"},{"key":"8_CR86","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/hep.21898","volume":"46","author":"R Sobesky","year":"2007","unstructured":"Sobesky R, Feray C, Rimlinger F, Derian N, Dos Santos A, Roque-Afonso AM, Samuel D, Brechot C, Thiers V (2007) Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 46:1704\u20131712","journal-title":"Hepatology"},{"key":"8_CR87","doi-asserted-by":"crossref","first-page":"e76867","DOI":"10.1371\/journal.pone.0076867","volume":"8","author":"C Spaniel","year":"2013","unstructured":"Spaniel C, Honda M, Selitsky SR, Yamane D, Shimakami T, Kaneko S, Lanford RE, Lemon SM (2013) microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection. PLoS One 8:e76867","journal-title":"PLoS One"},{"key":"8_CR88","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","volume":"309","author":"CL Jopling","year":"2005","unstructured":"Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577\u20131581","journal-title":"Science"},{"key":"8_CR89","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1073\/pnas.1516879113","volume":"113","author":"D Harouaka","year":"2016","unstructured":"Harouaka D, Engle RE, Wollenberg K, Diaz G, Tice AB, Zamboni F, Govindarajan S, Alter H, Kleiner DE, Farci P (2016) Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue. Proc Natl Acad Sci U S A 113:1375\u20131380","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR90","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/hep.510270534","volume":"27","author":"J Gosalvez","year":"1998","unstructured":"Gosalvez J, Rodriguez-Inigo E, Ramiro-Diaz JL, Bartolome J, Tomas JF, Oliva H, Carreno V (1998) Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. Hepatology 27:1428\u20131434","journal-title":"Hepatology"},{"key":"8_CR91","first-page":"1318","volume":"23","author":"GK Lau","year":"1996","unstructured":"Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY (1996) Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction. Hepatology 23:1318\u20131323","journal-title":"Hepatology"},{"key":"8_CR92","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/j.gastro.2009.07.050","volume":"137","author":"Y Liang","year":"2009","unstructured":"Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D, Cicalese L, Weiss H, Vargas G, Lemon SM (2009) Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137:1448\u20131458","journal-title":"Gastroenterology"},{"key":"8_CR93","doi-asserted-by":"crossref","first-page":"e6661","DOI":"10.1371\/journal.pone.0006661","volume":"4","author":"JD Stiffler","year":"2009","unstructured":"Stiffler JD, Nguyen M, Sohn JA, Liu C, Kaplan D, Seeger C (2009) Focal distribution of hepatitis C virus RNA in infected livers. PLoS One 4:e6661","journal-title":"PLoS One"},{"key":"8_CR94","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2013.01.019","volume":"58","author":"LW Meredith","year":"2013","unstructured":"Meredith LW, Harris HJ, Wilson GK, Fletcher NF, Balfe P, McKeating JA (2013) Early infection events highlight the limited transmissibility of hepatitis C virus in vitro. J Hepatol 58:1074\u20131080","journal-title":"J Hepatol"},{"key":"8_CR95","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2016.07.048","volume":"66","author":"DL Hedegaard","year":"2016","unstructured":"Hedegaard DL, Tully DC, Rowe IA, Reynolds GM, Bean DJ, Hu K, Davis C, Wilhelm A, Ogilvie CB, Power KA, Tarr AW, Kelly D, Allen TM, Balfe P, McKeating JA (2016) High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end stage liver disease. J Hepatol 66:28","journal-title":"J Hepatol"},{"key":"8_CR96","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","volume":"60","author":"F Kanwal","year":"2014","unstructured":"Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Serag HB (2014) HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. veterans with HCV. Hepatology 60:98\u2013105","journal-title":"Hepatology"},{"key":"8_CR97","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jhep.2009.01.019","volume":"50","author":"S Raimondi","year":"2009","unstructured":"Raimondi S, Bruno S, Mondelli MU, Maisonneuve P (2009) Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 50:1142\u20131154","journal-title":"J Hepatol"},{"key":"8_CR98","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jhep.2015.07.024","volume":"63","author":"A El-Shamy","year":"2015","unstructured":"El-Shamy A, Eng FJ, Doyle EH, Klepper AL, Sun X, Sangiovanni A, Iavarone M, Colombo M, Schwartz RE, Hoshida Y, Branch AD (2015) A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene. J Hepatol 63:1323\u20131333","journal-title":"J Hepatol"},{"key":"8_CR99","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1099\/jgv.0.000219","volume":"96","author":"B Korba","year":"2015","unstructured":"Korba B, Shetty K, Medvedev A, Viswanathan P, Varghese R, Zhou B, Roy R, Makambi K, Ressom H, Loffredo CA (2015) Hepatitis C virus genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk. J Gen Virol 96:2928\u20132937","journal-title":"J Gen Virol"},{"key":"8_CR100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2009.247","volume":"76","author":"ED Charles","year":"2009","unstructured":"Charles ED, Dustin LB (2009) Hepatitis C virus-induced cryoglobulinemia. Kidney Int 76:818\u2013824","journal-title":"Kidney Int"},{"key":"8_CR101","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ijc.29845","volume":"138","author":"T Iqbal","year":"2016","unstructured":"Iqbal T, Mahale P, Turturro F, Kyvernitakis A, Torres HA (2016) Prevalence and association of hepatitis C virus infection with different types of lymphoma. Int J Cancer 138:1035\u20131037","journal-title":"Int J Cancer"},{"key":"8_CR102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","volume":"59","author":"J Peveling-Oberhag","year":"2013","unstructured":"Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013) Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 59:169\u2013177","journal-title":"J Hepatol"},{"key":"8_CR103","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282:938\u2013941","journal-title":"Science"},{"key":"8_CR104","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2013-10-532895","volume":"123","author":"PP Ng","year":"2014","unstructured":"Ng PP, Kuo CC, Wang S, Einav S, Arcaini L, Paulli M, Portlock CS, Marcotrigiano J, Tarr A, Ball J, Levy R, Levy S (2014) B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins. Blood 123:1512\u20131515","journal-title":"Blood"},{"key":"8_CR105","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2015.364","volume":"35","author":"B Dai","year":"2016","unstructured":"Dai B, Chen AY, Corkum CP, Peroutka RJ, Landon A, Houng S, Muniandy PA, Zhang Y, Lehrmann E, Mazan-Mamczarz K, Steinhardt J, Shlyak M, Chen QC, Becker KG, Livak F, Michalak TI, Talwani R, Gartenhaus RB (2016) Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders. Oncogene 35:2979\u20132990","journal-title":"Oncogene"},{"key":"8_CR106","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/asheducation-2014.1.590","volume":"2014","author":"B Vannata","year":"2014","unstructured":"Vannata B, Zucca E (2014) Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. hematology\/the education program of the American Society of Hematology. Am Soc Hematol Educ Program 2014:590\u2013598","journal-title":"Am Soc Hematol Educ Program"},{"key":"8_CR107","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","volume":"77","author":"VM Sung","year":"2003","unstructured":"Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM (2003) Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77:2134\u20132146","journal-title":"J Virol"},{"key":"8_CR108","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/hep.22550","volume":"48","author":"S Marukian","year":"2008","unstructured":"Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM, Dustin LB (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843\u20131850","journal-title":"Hepatology"},{"key":"8_CR109","first-page":"321","volume":"369","author":"JM Pawlotsky","year":"2013","unstructured":"Pawlotsky JM (2013) Treatment of chronic hepatitis C: current and future. Curr Top Microbiol Immunol 369:321\u2013342","journal-title":"Curr Top Microbiol Immunol"},{"key":"8_CR110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","volume":"65","author":"M Reig","year":"2016","unstructured":"Reig M, Marino Z, Perello C, Inarrairaegui M, Ribeiro A, Lens S, Diaz A, Vilana R, Darnell A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J (2016) Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol 65:719","journal-title":"J Hepatol"},{"key":"8_CR111","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.03540-13","volume":"88","author":"M Yi","year":"2014","unstructured":"Yi M, Hu F, Joyce M, Saxena V, Welsch C, Chavez D, Guerra B, Yamane D, Veselenak R, Pyles R, Walker CM, Tyrrell L, Bourne N, Lanford RE, Lemon SM (2014) Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol 88:3678\u20133694","journal-title":"J Virol"},{"key":"8_CR112","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/cr.2014.116","volume":"24","author":"J Chen","year":"2014","unstructured":"Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, Pan Y, Du J, Guo M, Cao H, Chen H, Wang Z, Pei R, Wang Q, Pan L, Niu J, Chen X, Tang H (2014) Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res 24:1050\u20131066","journal-title":"Cell Res"},{"key":"8_CR113","doi-asserted-by":"crossref","first-page":"25087","DOI":"10.18632\/oncotarget.7837","volume":"7","author":"ML Tornesello","year":"2016","unstructured":"Tornesello ML, Buonaguro L, Izzo F, Buonaguro FM (2016) Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. Oncotarget 7:25087\u201325102","journal-title":"Oncotarget"}],"container-title":["Advances in Experimental Medicine and Biology","Infectious Agents Associated Cancers: Epidemiology and Molecular Biology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-5765-6_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T21:42:37Z","timestamp":1659649357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-5765-6_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811057649","9789811057656"],"references-count":113,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-5765-6_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}